MarketPeel
Insider Trading Intelligence
AK

Andrew T. Kaplan

SGRY
DIRECTOR · SURGERY PARTNERS, INC. · CIK 0001752059
FILING MIX · LIFETIME50%/50%
BUYS
3
SELLS
3
TOTAL VALUE
$396.11M
COMPANIES
2
ACTIVE SINCE
Dec 2023
HOLDINGS NOW
76,676,960
AVG SELL PX
$33.44
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Andrew T. Kaplan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-4.47%+0.91%-5.38%-5.38%
14d1+100.00%+1.95%+1.31%+0.64%+0.64%
30d1+0.00%-20.28%
60d1+0.00%-24.62%+5.37%-29.99%-29.99%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SGRY · 50,421,379 shares · as of Dec 19, 2023
012,605,34525,210,69037,816,03450,421,379SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 3 buys / 3 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
17,857,14317,857,143Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
17,857,1430Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
8,398,438$16.00$134.38M26,255,581Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,30038,300Apr 16, 2026Apr 20, 2026View →
SGRY
SURGERY PARTNERS, INC.
SALE
474,40749,946,972Dec 19, 2023Dec 21, 2023View →
SGRY
SURGERY PARTNERS, INC.
SALE
7,826,870$33.44$261.73M50,421,379Dec 19, 2023Dec 21, 2023View →
Other insiders · SGRY
Loading peer insiders…
About this filer
CIK 0001752059
ROLE
Director
PRIMARY
SGRY
COMPANIES
2
ACTIVE SINCE
Dec 2023
MARKETPEEL · /INSIDER/0001752059DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback